Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lotti

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Science (New York, N.Y.)|October 11, 1985
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusR S Chang, V J Lotti, R L Monaghan, et al.
Journal of Medicinal Chemistry|March 5, 1993
Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazolesW T Ashton, C L Cantone, L L Chang, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|September 1, 1991
Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonistsN B Mantlo, P K Chakravarty, D L Ondeyka, et al.
Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|November 12, 1993
(Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonistsD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindolesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|December 23, 1994
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|November 12, 1993
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylatesW T Ashton, S M Hutchins, W J Greenlee, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Science (New York, N.Y.)|October 11, 1985
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusR S Chang, V J Lotti, R L Monaghan, et al.
Journal of Medicinal Chemistry|March 5, 1993
Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazolesW T Ashton, C L Cantone, L L Chang, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|September 1, 1991
Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonistsN B Mantlo, P K Chakravarty, D L Ondeyka, et al.
Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|November 12, 1993
(Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonistsD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindolesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|December 23, 1994
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|November 12, 1993
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylatesW T Ashton, S M Hutchins, W J Greenlee, et al.
Pageof 13